Andere Sprachen Innoviva, Inc.

Aktien

A2AC9U

US45781M1018

INVA

Pharmazeutika

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 10.07.2026			% 5 Tage	Veränd. 1. Jan.
22.24 ^USD	+0.18%		-0.31%	+11.26%

18.06.	Innoviva, Inc. (NasdaqGS:INVA) hat die LYNX-Plattform von Lyndra Therapeutics, Inc. übernommen	CI
16.06.	Innoviva Specialty Therapeutics schließt Lizenzvereinbarung mit Dr. Reddy's für Xacduro ab	MT

Andere Sprachen

29.06.	Innoviva, Inc.(NasdaqGS:INVA) dropped from Russell Small Cap Comp Growth Benchmark
29.06.	Innoviva, Inc.(NasdaqGS:INVA) dropped from Russell 2500 Growth Benchmark
29.06.	Innoviva, Inc.(NasdaqGS:INVA) dropped from Russell 2000 Growth Benchmark
29.06.	Innoviva, Inc.(NasdaqGS:INVA) dropped from Russell 3000E Growth Benchmark
29.06.	Innoviva, Inc.(NasdaqGS:INVA) dropped from Russell 2000 Growth-Defensive Index
29.06.	Innoviva, Inc.(NasdaqGS:INVA) dropped from Russell 3000 Growth Benchmark
22.06.	Nortiva Bio Launches to Develop Long-Acting Oral Medicines
18.06.	Nortiva Bio Launches to Develop Long-Acting Oral Medicines
18.06.	Innoviva, Inc. acquired LYNX platform from Lyndra Therapeutics, Inc.
16.06.	Innoviva' Specialty Therapeutics Unit Signs Licensing Deal With Dr. Reddy's for Xacduro
16.06.	Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy’s for XACDURO® in Select International Markets
01.06.	Innoviva to Participate in Upcoming Investor Conferences
18.05.	Innoviva, Inc. Announces Board Changes
06.05.	Innoviva: Q1 Earnings Snapshot
06.05.	Earnings Flash (INVA) Innoviva, Inc. Reports Q1 Revenue $98.0M, vs. FactSet Est of $101.6M
06.05.	Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 5, 2025.
06.05.	Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress
06.05.	Innoviva, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
15.04.	Beacon Biosignals, Inc. announced that it has received $103.280666 million in funding from a group of investors
06.04.	Beacon Biosignals, Inc. announces tranche update
23.03.	Aurinia Pharmaceuticals Inc. Announces Board and Executive Changes
23.03.	Aurinia Pharmaceuticals Inc. Announces Chief Executive Officer Changes
25.02.	Innoviva: Q4 Earnings Snapshot
25.02.	Earnings Flash (INVA) Innoviva, Inc. Reports Q4 Revenue $114.6M, vs. FactSet Est of $102.6M
25.02.	Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 5, 2025.